The FDA agrees that the Company may follow 505(b)(2) regulatory pathway to non-invasively treat basal cell carcinoma (BCC) of ...

Biomedical engineers at Duke University have developed a platform that combines automated wet lab techniques with artificial ...

Avak Kahvejian, PhD, a general partner with biotech incubator Flagship Pioneering, discusses how AI is rearchitecting methods ...

Three draft recommendation documents published on Wednesday are intended to guide drug sponsors and accelerate the ...

Jacobs School researcher Thomas Grant has secured a $2.18 million grant to pioneer a protein-studying tool that could lead to ...

Broad-spectrum Antiviral NV-387 At Phase II Clinical Trial Stage – NV-387 Could Become a Revolutionary Antiviral for ...

The "Artificial Intelligence In Pharmaceutical Market Report by Technology, Offering, Application, Deployment Mode, Countries and Company Analysis, 2025-2033" report has been added to ...

These criteria ensure that the drug offers a genuine therapeutic difference, a requirement for its effectiveness against evolving AMR. Considering it can take 15 years and cost over $1 billion to ...

AAVB-039 is an intra-retinal AAV8-intein-mediated investigational gene therapy targeting the gene associated with Stargardt ...

Deep EigenMatics received the current U.S. patent (US 12,424,300 B1) for inventing a two headed neural network method for jointly generating the sequence and structure of a protein, given a condition ...

Viva Biotech is acknowledged for its pioneering AI-driven drug discovery platforms that accelerate timelines, reduce costs, ...

Keeping products like Gatorade and Cheetos colorful without the artificial dyes that U.S. consumers are increasingly ...